Deal yields single-use fluid-management solutions

A deal said to move the totally disposable bioprocessing factory "one step closer to reality" has been struck by single-use bioprocessing equipment and services supplier Sartorius Stedim Biotech and SAFC Biosciences, a provider of cell culture materials and development services for upstream and downstream processing.

The agreement combines Sartorius Stedim Biotech's capabilities in filtration and liquid handling systems with SAFC Biosciences' proficiency in the development and manufacturing of cell culture media and downstream purification products, according to an announcement. The partners aim to capture and analyze data from the combined filtration and buffer technologies. They will also provide data on media buffer extractability and leachability.

Each company will offer its products with the support of its partner to serve customers in solution creation, validation support, process improvement and technical support, the announcement says.

- here's the announcement

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.